Information about Ibs Direct Investments
My details
*
*
*

Ibs Direct Investments (SRL)

nl

55200036

Company information

Status
Active

KVK number

55200036

VAT Number

NL 851605497 B01
Established
26-04-2012
Last balance sheet year
2025
Company size
Small 0 FTE
Legal form
Société à responsabilité limitée (SRL)
RSIN number
851605497
Trade names
  • IBS Capital Allies
Principal activity
Advisering op het gebied van management en bedrijfsvoering (geen public relations en organisatie-adviesbureaus)
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Ibs Direct Investments

2025 2024 2023 2022
Equity € 539.810 2,19% € 528.229 3,92% € 508.318 4,24% € 487.656
Employees 0 0 0 0

Frequently asked questions

What is the KVK number of Ibs Direct Investments?
The KVK number of Ibs Direct Investments is 55200036
What is the VAT number of Ibs Direct Investments?
The VAT number of Ibs Direct Investments is NL 851605497 B01.
Wat is the PEPPOL ID of Ibs Direct Investments?
There is no information available about the PEPPOL ID of Ibs Direct Investments or the company is not yet registered on the PEPPOL network.
When was Ibs Direct Investments founded?
Ibs Direct Investments was founded on 26-04-2012.
What is the address of Ibs Direct Investments?
The current registered office of Ibs Direct Investments is located at De Cuserstraat 87, 1081 CN Amsterdam.
When was the last time Ibs Direct Investments filed their annual financial statements?
The most recent financial statements of Ibs Direct Investments were filed on 31-12-2025.
How many employees does Ibs Direct Investments have?
There are currently no employees working at Ibs Direct Investments or no workforce information is available.
What is the annual turnover of Ibs Direct Investments?
There is no turnover available for Ibs Direct Investments.

Sources